Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.79 |
| ▸ | CCR8 | P51685 | 5/20 | 0.79 |
| ▸ | CCR5 | P51681 | 4/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28297883 | 0.89 | CCR1 (1.00) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL136654 | 0.89 | CCR1 (1.00) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| Water SCHEMBL7574656 | 0.87 | CCR1 (0.86) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL29569064 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL29354722 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL28229864 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL11731095 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL30753486 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| Water SCHEMBL28424933 | 0.87 | CCR1 (0.95) | CCR1CCR8CCR5L3MBTL1NPC1 | |
| SCHEMBL28430950 | 0.83 | CCR1 (0.86) | CCR1CCR8CCR5L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546168-A4 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2008-03-12 | — | — | EP | claimed |
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | PURDUE RESEARCH FOUNDATION | 2006-05-25 | — | — | US | claimed |
| EP-1546168-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2004012667-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2004-02-12 | — | — | WO | claimed |
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | PURDUE RESEARCH FOUNDATION | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | TP53, POLI, POLK | CCR1 4643/4885CCR8 4400/4885CCR5 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.